94 related articles for article (PubMed ID: 32945396)
1. Angiotensin‑converting enzyme‑2 improves diabetic nephropathy by targeting Smad7 for ubiquitin degradation.
Chen Z; Chen X; Bai Y; Diao Z; Liu W
Mol Med Rep; 2020 Oct; 22(4):3008-3016. PubMed ID: 32945396
[TBL] [Abstract][Full Text] [Related]
2. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
3. MiR-32-5p knockdown inhibits epithelial to mesenchymal transition and renal fibrosis by targeting SMAD7 in diabetic nephropathy.
Wang HJ; Liu H; Lin YH; Zhang SJ
Hum Exp Toxicol; 2021 Apr; 40(4):587-595. PubMed ID: 32959695
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation.
Liu Z; Huang XR; Chen HY; Fung E; Liu J; Lan HY
Hypertension; 2017 Oct; 70(4):822-830. PubMed ID: 28808068
[TBL] [Abstract][Full Text] [Related]
5. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
[TBL] [Abstract][Full Text] [Related]
6. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
7. Latent TGF-β1 protects against diabetic kidney disease via Arkadia/Smad7 signaling.
Wu W; Huang XR; You Y; Xue L; Wang XJ; Meng X; Lin X; Shen J; Yu X; Lan HY; Chen H
Int J Biol Sci; 2021; 17(13):3583-3594. PubMed ID: 34512167
[TBL] [Abstract][Full Text] [Related]
8. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
[TBL] [Abstract][Full Text] [Related]
9. BMP-7 enhances SnoN mRNA expression in renal tubular epithelial cells under high-glucose conditions.
Wang Y; Xiao Y; Li S; Shi L; Liu L; Zhang Y; Shi M; Guo B
Mol Med Rep; 2017 Sep; 16(3):3308-3314. PubMed ID: 28765970
[TBL] [Abstract][Full Text] [Related]
10. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
[TBL] [Abstract][Full Text] [Related]
11. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN.
Xu H; Sun F; Li X; Sun L
Hum Cell; 2018 Jan; 31(1):22-32. PubMed ID: 28707079
[TBL] [Abstract][Full Text] [Related]
13. SnoN upregulation ameliorates renal fibrosis in diabetic nephropathy.
Liu L; Shi M; Wang Y; Zhang C; Su B; Xiao Y; Guo B
PLoS One; 2017; 12(3):e0174471. PubMed ID: 28350874
[TBL] [Abstract][Full Text] [Related]
14. Protective Effect of Znt7 on High Glucose-Induced Epithelial-to-Mesenchymal Transition in Renal Tubular Epithelial Cells.
Zhang X; Lian X; Liang D; Zhang L; Liu S; Yang L; Chi ZH; Gu HF
Kidney Blood Press Res; 2018; 43(2):500-512. PubMed ID: 29627824
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathy.
Tian Y; Liao F; Wu G; Chang D; Yang Y; Dong X; Zhang Z; Zhang Y; Wu G
Toxicol Mech Methods; 2015; 25(8):645-52. PubMed ID: 26108275
[TBL] [Abstract][Full Text] [Related]
16. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
[TBL] [Abstract][Full Text] [Related]
17. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
18. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587
[TBL] [Abstract][Full Text] [Related]
19. Serum response factor provokes epithelial-mesenchymal transition in renal tubular epithelial cells of diabetic nephropathy.
Zhao L; Chi L; Zhao J; Wang X; Chen Z; Meng L; Liu G; Guan G; Wang F
Physiol Genomics; 2016 Aug; 48(8):580-8. PubMed ID: 27260841
[TBL] [Abstract][Full Text] [Related]
20. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
Kang MK; Park SH; Choi YJ; Shin D; Kang YH
J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
